|
JJ Minguell, A Pereira, P Bartholomew, G Lasala. The intra-thecal infusion by lumbar puncture of mesenchymal stem cells into healthy rabbits is safe and devoid of neurological or clinical complications. (In Press)
G Lasala, J Minguell. Therapeutic Angiogenesis in patients with severe limb ischemia by transplantation of a combination stem cell product. (Submitted)
G Lasala, J Minguell. Vascular diseases and stem cell therapies. Brit. Med. Bull. 2011; 98: 187 – 97.
G Lasala, Lorino R, J Minguell L. Myocardial implantation of a combination stem cell product by using a transendocardial MYOSTAR injection catheter: A technical assessment. Acute Cardiac Care 2011 March; 13(1): 40-2
Lasala GP, Silva JA, Kusnick BA, Minguell JJ. Combination stem cell therapy for the treatment of medically refractory coronary ischemia: a phase 1 study. Cardiov Rev Med 2010 January 7 [Epub ahead of print]
Lasala GP, Silva JA, Gardner PA , Minguell JJ. Combination of stem cell therapy for the treatment of severe limb ischemia. Angiology. 2010, 61:551-556
Minguell JJ, Lasala GP. Intracoronary infusion of a combination of bone marrow-derived stem cells in dogs. Exp Clin Cardiol 2010 15:17-20
Lasala G, Minguell J. Combination of human adult stem cell therapy for patients with a recent myocardial infarction undergoing coronary artery by-pass surgery. Int Soc Stem Cell Res (Abstract) 2010- 177
Lasala G, Silva J, Minguell J. Combination stem cell therapy for the treatment of acute myocardial infarction. Cath and Cardiovasc Int (Abstract) 2010 Supp. 75- B009
Minguell,JJ. Umbilical cord-derived mesenchymal stem cells, in Regenerative Medicine Using Pregnancy-Specific Biological Substances, Eds. Niranjan Bhattacharya and Stubblefield P. Springer, 2011 ISBN: 9781848827172.
Lasala G, Minguell JJ. Bone marrow-derived stem/progenitor cells: their use in clinical studies for the treatment of myocardial Infarction. Heart Lung Circ. 2009; 18:171-80
Nissen SE, Tardif JC, Nicholls SJ, Revkin JH, Shear CL, Duggan WT, Ruzyllo W, Bachinsky WB, Lasala GP, Tuzcu EM; Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med. 2007;356: 1304-16.
Minguell JJ, Erices A. Mesenchymal stem cells and the treatment of cardiac disease. Exp Biol Med 2006; 231:39-49.
Rivera FJ, Sierralta WD, Minguell JJ, Aigner L. Adult hippocampus derived soluble factors induce neuronal-like phenotype in mesenchymal stem cells. Neurosci Lett 2006; 406:49-54.
Minguell JJ, Fierro FA, Epuñan MJ, Erices AA, Sierralta WD. Nonstimulated human uncommitted MSC express cell markers of mesenchymal and neural lineages. Stem Cells Dev 2005; 14:408-14.
Florenzano F, Minguell JJ. Autologous mesenchymal stem cell transplantation after acute myocardial infarction. Am J Cardiol 2005;95:435.
Allers C, Sierralta WD, Neubauer S, Rivera F, Minguell JJ, Conget PA. Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation 2004;78: 503-8
Santa María L, Rojas CV, Minguell JJ. Signals from damaged but not undamaged skeletal muscle induce myogenic differentiation of rat bone-marrow-derived mesenchymal stem cells. Exp Cell Res 004;300:418-26.
Lasala GP et al. "Phase I clinical trial using a combination of stem cells to treat Coronary Ischemia". Fifth International Conference on Cell Therapy for Cardiovascular Disease. The New York Academy of Medicine, NY, January, 2009. Conference Invitation
Lasala GP et al. "Combination stem cell therapy for the treatment of Limb Ischemia: a phase 1 study. 58th Annual Scientific Sessions, Am College Cardiology and ACC.09 & i2 Summit: Innovation in Intervention. March 28-31, 2009. Orlando, Florida.
Lasala GP et al. Stem cell combination therapy for the treatment of medically refractory coronary ischemia. European Congress of Cardiology, Barcelona, Sept 2009.
Lasala GP et al. Stem cell combination therapy for the treatment of limb ischemia. European Congress of Cardiology, Barcelona, Sept 2009
Lasala GP et al. Combination stem cells therapy for the treatment of severe limb ischemia: Phase I & II clinical trials. World Stem Cell Summit, Baltimore, Oct 2009
Lasala GP et al. Combination stem cell therapy for the treatment of acute myocardial infarction. Cell Res. 33rd Annual Scientific Sessions, Society for Cardiovascular Angiography and Interventions, San Diego, May 2010.
Lasala GP et al. Combination of human adult stem cell therapy for patients with a recent myocardial infarction undergoing coronary artery by-pass surgery. ISSCR 8th Annual Meeting. International Society for Stem Cell Research, San Francisco, June 2010.
Lasala GP. Stem cell therapy – Severe Limb Ischemia. Phacilitate Cell and Gene Therapy Forum 2011. Washington DC. January 26, 2011.
Lasala GP et al. Therapeutic angiogenesis in patients with severe limb ischemia by transplantation of an autologous bone marrow-derived combination stem cell product. 60th Annual Scientific Session & Innovation in Intervention: 12 Summit 2011. New Orleans, LA. April 3, 2011
|
